Stockreport

Genmab's Outlook Beyond Darzalex's Patent Cliff [Seeking Alpha]

Genmab A/S - American Depositary Shares  (GMAB) 
PDF The company's robust late-stage pipeline could offset DARZALEX revenue loss with new product launches expected between 2027-2031. Genmab's strong balance sheet with $ [Read more]